Stay updated on Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry (v3.3.3, 2025-12-19) was added to the record history, noting an update to the Study Status section.SummaryDifference0.4%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe version history shows additional Study Status entries reflecting ongoing updates to the trial status, but there are no changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedA new 2025-11-25 entry updates the study status to Active, not recruiting and changes to Contacts/Locations, Study Design, Study Status, and Recruitment Status. The previous 'Recruiting' status was removed on 2025-09-12.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page history now includes a new revision entry v3.3.2 and removes the previous entry v3.2.0.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved a site-wide government funding/operating status notice from the page header; the study record history and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedThe old and new screenshots show the same version history entries with only minor UI refinements (layout and styling); no core study data, statuses, or records were added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page.